News
Local
Sports
Business
Entertainment
Lifestyle
Opinion
Real Estate News
Hot Property
eNewspaper
________________
Subscriptions
Manage Subscription
EZPay
Delivery Issue
eNewspaper
Subscribe
Subscriber Terms
Gift Subscription Terms
Manage Subscription
EZPay
Delivery Issue
eNewspaper
Subscribe
Subscriber Terms
Gift Subscription Terms
About Us
Contact us
Our Journalism Explained
Newsletters
Readers Rep
Careers
Events
Historical Archives
Podcasts and Livestreams
U-T Store
Contact us
Our Journalism Explained
Newsletters
Readers Rep
Careers
Events
Historical Archives
Podcasts and Livestreams
U-T Store
Events
Advertising
Place an ad
Media kit
Rate book
Report an ad problem
Cars
Classifieds
Eldercare Directory
Jobs
Newspaper ad directory
Newspaper special sections
Real Estate
Sponsored
Stats Digital
Place an ad
Media kit
Rate book
Report an ad problem
Cars
Classifieds
Eldercare Directory
Jobs
Newspaper ad directory
Newspaper special sections
Real Estate
Sponsored
Stats Digital
Jobs
CaregiverSD
Community papers
Del Mar Times
Encinitas Advocate
La Jolla Light
PB Monthly
Point Loma-OB Monthly
Pomerado News
Poway News Chieftain
Ramona Sentinel
Rancho Bernardo
Rancho Santa Fe Review
Del Mar Times
Encinitas Advocate
La Jolla Light
PB Monthly
Point Loma-OB Monthly
Pomerado News
Poway News Chieftain
Ramona Sentinel
Rancho Bernardo
Rancho Santa Fe Review
Games, Puzzles, and Crossword
Crossword
Sudoku
Crossword
Sudoku
Obituaries
Death Notices
Place an obituary
Death Notices
Place an obituary
U-T En Español
Deportes
Comunidad
Espectáculos
Cierre de Edición, fotos, videos
Noticias
Deportes
Comunidad
Espectáculos
Cierre de Edición, fotos, videos
Noticias
Privacy and Terms
Privacy
Terms
Advertising terms
Privacy
Terms
Advertising terms
Copyright © 2022, The San Diego Union-Tribune |
CA Notice of Collection
|
Do Not Sell My Personal Information
Sections
Sports
Business
Entertainment
Lifestyle
Opinion
Real Estate
Obituaries
eNewspaper
Newsletters
Show Search
Search Query
Submit Search
COVID-19
For subscribers
Phenomenal women
Latino life
Crossword
Sudoku
About Us
Contact us
Community Advisory Board
Readers Rep
Careers
Events
Historical Archives
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
San Diego Stocks
San Diego Stocks
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
COMPASS Pathways Plc - American Depository Shares
(NQ:
CMPS
)
6.810
+0.230 (+3.50%)
Streaming Delayed Price
Updated: 1:55 PM EDT, Mar 9, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about COMPASS Pathways Plc - American Depository Shares
< Previous
1
2
...
13
14
15
16
17
18
19
20
21
...
31
32
Next >
Revive Therapeutics, Compass Pathways Among Top Psychedelic Movers Of Today
↗
November 28, 2022
Via
Benzinga
Cannabis Category Performances Last Week Ranged From +5.2% To -2.3%
↗
November 27, 2022
The 5 categories in the cannabis sector perform quite differently week to week and last week was no exception. This article is a summary of how each category performed last week, in descending order...
Via
Talk Markets
Psychedelic Stock Gainers And Losers From November 25, 2022
↗
November 25, 2022
Via
Benzinga
Psychedelic Stock Gainers And Losers From November 24, 2022
↗
November 24, 2022
Via
Benzinga
Psychedelic Stock Gainers And Losers From November 23, 2022
↗
November 23, 2022
Via
Benzinga
Psychedelics And Treatment-Resistant Depression: An Overview Of COMPASS' Latest Trial Outcomes
↗
November 16, 2022
(Part one of a four-part series)
Via
Benzinga
COMPASS Pathways plc (CMPS) Q3 2022 Earnings Call Transcript
↗
November 03, 2022
CMPS earnings call for the period ending September 30, 2022.
Via
The Motley Fool
Compass Pathways: Q3 Earnings Insights
↗
November 03, 2022
Compass Pathways (NASDAQ:CMPS) reported its Q3 earnings results on Thursday, November 3, 2022 at 07:00 AM. Here's what investors need to know about the announcement.
Via
Benzinga
Psychedelics And Treatment-Resistant Depression: Companies Weigh In On The Important Issue
↗
November 23, 2022
(Part three of a four-part series) Have a look at previous stories:
Via
Benzinga
Psychedelic Stock Gainers And Losers From November 22, 2022
↗
November 22, 2022
Via
Benzinga
Psyched: Musk's Empathy Tweets, Psychedelics In Congress, Oregon's Opt-Outs, MAPS' MDMA Trial And More
↗
November 21, 2022
Elon Musk Joins Twitter Conversation Around Psychedelics: A Debate On Empathy
Via
Benzinga
Psychedelic Stock Gainers And Losers From November 21, 2022
↗
November 21, 2022
Via
Benzinga
Psychedelic Drug Stocks Index Continued To Decline Last Week
↗
November 20, 2022
This article highlights the performances of the 6 constituents in the munKNEE Psychedelic Drug Stocks Index last week and in the last 3 weeks and the extent to which each company is likely to encounter...
Via
Talk Markets
Biomind Labs, ATAI Life Sciences Among Top Psychedelic Movers Of Today
↗
November 18, 2022
Via
Benzinga
Psychedelics And Treatment-Resistant Depression: Reactions To COMPASS' Published Results
↗
November 18, 2022
(Part two of a four-part series) See previous story in this series: Psychedelics And Treatment-Resistant Depression: An Overview Of COMPASS’ Latest Trial Outcomes
Via
Benzinga
Revive Therapeutics, GH Research Among Top Psychedelic Movers Of Today
↗
November 17, 2022
Via
Benzinga
Psychedelic Stock Gainers And Losers From November 16, 2022
↗
November 16, 2022
Via
Benzinga
GH Research, Seelos Therapeutics Among Top Psychedelic Movers Of Today
↗
November 15, 2022
Via
Benzinga
Clinical Stage Psychedelic Stock Index Up 6%; Therapy Clinic Stocks Down 8%
↗
November 14, 2022
We highlight the performance of our Psychedelic Drug Stocks Index and the 6 psychedelic stocks that research the treatment of a variety of mental illnesses based on the use of different psychedelic...
Via
Talk Markets
A Comparison Of 5 Psychedelic ETFs And Indices
↗
November 11, 2022
A look at 2 psychedelic ETFs and 3 tracking (non-trading) indices in the sector.
Via
Talk Markets
Compass Pathways, Mind Medicine Among Top Psychedelic Movers Of Today
↗
November 10, 2022
GAINERS: Compass Pathways (NASDAQ:CMPS) shares closed up 12.17% at $10.05
Via
Benzinga
Seelos Therapeutics, GH Research Among Top Psychedelic Movers Of Today
↗
November 09, 2022
GAINERS: GH Research (NASDAQ:GHRS) shares closed up 7.91% at $9.96 LOSERS:
Via
Benzinga
Psychedelic Stock Gainers And Losers From November 8, 2022
↗
November 08, 2022
GAINERS: Small Pharma (OTC:DMTTF) shares closed up 3.85% at $0.14
Via
Benzinga
The Psychedelic Drug Stocks Index Continued To Plummet Last Week
↗
November 07, 2022
In total, the Psychedelic Drug Stock Index went down 5.8% last week and is now down 64.9% YTD.
Via
Talk Markets
Compass Pathways, Allied Among Top Psychedelic Movers Of Today
↗
November 07, 2022
GAINERS: Allied (OTC:ALID) shares closed up 4.10% at $0.44
Via
Benzinga
EXCLUSIVE: Insider's Peek At Mammoth Of Psychedelics VCs, Palo Santo, Market Subverticals & Informal Guidance
↗
November 07, 2022
(Part four of a four-part series) See previous stories in this series:
Via
Benzinga
COMPASS Pathways Shares Q3 2022 Financial Results, Business News & Term's Highlights
↗
November 04, 2022
Psychedelics mental healthcare firm COMPASS Pathways (NASDAQ: CMPS) reported its financial outcomes for the third quarter ended 30 September 2022 and gave an update on its most recent pipeline and...
Via
Benzinga
Psychedelic Stock Gainers And Losers From November 3, 2022
↗
November 03, 2022
GAINERS: Compass Pathways (NASDAQ:CMPS) shares closed up 4.80% at $10.27
Via
Benzinga
Psyched Wellness is The First Public Company To Bring Amanita Muscaria For Human Consumption To The U.S.
↗
November 03, 2022
Easily identified by its red cap covered with white dots and a white stem, the Amanita muscaria mushroom is probably the most famous and easily recognizable mushroom in the world. Popularized by Lewis...
Via
Benzinga
COMPASS Pathways Announces Third Quarter 2022 Financial Results and Business Highlights
November 03, 2022
From
COMPASS Pathways
Via
GlobeNewswire
< Previous
1
2
...
13
14
15
16
17
18
19
20
21
...
31
32
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
